Global pharma major Lupin Limited (Lupin) announced the launch of liraglutide injection, 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pen, in the United States. Liraglutide injection, 18 mg/3 mL ...

Lupin has announced the launch of its Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen in the United States.

The product is bioequivalent to Novo Nordisk Inc's Victoza injection. It is indicated as an adjunct to diet and exercise to ...

Victoza (liraglutide) solution for injection is prescribed to help manage blood sugar and reduce major heart-related risks. Victoza is not safe to use while pregnant and may not be safe to use while ...

Dec 23 (Reuters) - The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' (HIK.L), opens new tab generic version of Novo Nordisk's diabetes drug (NOVOb.CO), opens new tab ...